News

Treatment slows moderate to severe Alzheimer's disease

BMJ 2003; 326 doi: 10.1136/bmj.326.7393.784 (Published 12 April 2003)
Cite this as: BMJ 2003;326:784.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Janice Hopkins Tanne
  1. New York

    For the first time, a treatment has been shown to slow the mental and physical decline of patients with moderate to severe Alzheimer's disease by about six months (New England Journal of Medicine 2003;348:1333-41).

    The US researchers conducted a double blind, randomised controlled trial of memantine. The drug had been marketed in Germany by Merz Pharmaceuticals for a decade for Parkinson's disease and other neurodegenerative diseases before being licensed in May 2002 by the European Union …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular